The largest database of trusted experimental protocols

4 protocols using c57bl 6 b6 mice

1

Tamoxifen-Induced Gene Deletion in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild-type (WT) C57BL/6 (B6) mice were purchased from Koatech. Raptorfl/fl, Rictorfl/fl, and Ptenfl/fl mice [44 (link),45 (link)] were crossed with the tamoxifen-inducible Cre (Ert2Cre) transgenic mice (B6.129-Gt(ROSA)26Sortm1(cre/ERT2)Tyj/J, The Jackson Laboratory). To delete floxed genes, tamoxifen (0.1 mg/ear, Sigma-Aldrich, St. Louis, MO, USA) was applied to the ear skin daily for 5 days. Genotyping was performed by using PCR or immunoblotting. All animal experimentations were conducted in accordance with guidelines and approval of the International Animal Care and Use Committees of Hallym University (Hallym 2020-28, Hallym 2021-59).
+ Open protocol
+ Expand
2

Genetically Modified Mice for Immunology Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6 (B6) mice (7 to 8 weeks old) were purchased from Koatech (Pyeongtaek, Korea). Crif1fl/fl mice were a generous gift from M. Shong (Chungnam University, Korea) and were crossed with Foxp3YFP-Cre (Jackson strain no. 016959) or Foxp3EGFP-cre-ERT2 (Jackson strain no. 016961) mice. Other purchased mice were B6 CD45.1 congenic (Jackson strain no. 002014), T-betfl/fl (Jackson strain no. 022741), Ifng KO (Jackson strain no. 002287), Il4 KO (Jackson strain no. 002253), Rag1 KO (Jackson strain no. 002216), and ROSA26tdtomato mice (Jackson strain no. 007909) mice. All of these Jackson strain mice were purchased from Jackson Laboratory. Gata3fl/fl mice were a gift from Professor G. Ryol Lee (Sogang University, Korea). All strains were maintained on a B6 background and crossed as necessary to generate the desired genotypes. Age- and gender-matched male and female mice between 4 and 8 weeks of age were used in the study. Littermates were randomly assigned to experimental groups. All mice were bred and maintained under specific pathogen–free conditions at the Clinical Research Institute, SNUH. All in vivo experiments were approved by the Institutional Animal Care and Use Committee of the Clinical Research Institute, SNUH, and were conducted in accordance with the relevant guidelines and regulations.
+ Open protocol
+ Expand
3

Gene Editing in Hemophilic Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6 (B6) mice were purchased from Koatech (PyeongTaek, Gyeonggi, Korea). B6.FVIII intron 22 inversion (F8I22I) and B6.FIX knockout (F9Mut) were generated by CRISPR-Cas9–based gene editing (fig. S7) (56 (link)). Seven- to 9-week-old male mice were subjected to further experiments. B6 and each hemophilia mice were randomly divided, and half of them were injected LNP packed SpCas9 mRNA and highly modified sgRNA (LNP-CRISPR-mAT) three times with 2-week interval. Injection solution was prepared by mixing 1.2 mpk of LNP-CRISPR-mAT and warm saline up to 600 μl and was injected via the intravenous route. The 600 μl of injection solution could not induce hydrodynamic gene delivery in the liver (fig. S8). B6 mice have been subjected to repeated blood sampling via tail vein for 18 weeks. Hemophilia mice were euthanized at 8 weeks after the first LNP-CRISPR-mAT injection. A total of 450 μl of fresh blood was collected from the inferior vena cava and mixed with 50 μl of 3.2% sodium citrate, and plasma was prepared by collecting supernatant after centrifugation. After blood sampling, each organ was collected without perfusion, a part of the tissues was fixed by formalin, and the remains were used for genomic DNA extraction. This study was approved by the Institutional Animal Care and Use Committees of Seoul National University (SNU-200715-2) and was conducted under approved guidelines.
+ Open protocol
+ Expand
4

Mouse Model of Type 2 Immunity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild type (WT) C57BL/6 (B6) mice were obtained from Koatech (Pyeongtaek, Korea). RAG-1 knockout (KO) (B6.129S7-Rag1tm1Mom/J), floxed HIF-1α (B6.129-Hif1atm3Rsjo/J), floxed HIF-2α (Epas1tm1Mcs/J), K14Cre (B6N.Cg-Tg(KRT14-cre)1Amc/J) mice were obtained from The Jackson Laboratory (Bar Harbor, ME). All animal experimentations were conducted in accordance with the guidelines and approval of the International Animal Care and Use Committees of Hallym University (Hallym 2021-59) and all animal experiments complied with the ARRIVE guidelines. We used age- and sex-matched control and experiment mice. To deplete ILCs, anti-CD90 antibody (BioXcell, Lebanon, NH) was administered i.p. every two days. For recombinant TSLP and IL-33 injection experiments, 62.5 ng of each cytokine (Biolegend, San Diego, CA) was injected subcutaneously every day for 14 days.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!